Upon further validation using groups treated with an IL‐4 inhibitor and a p‐STAT6 inhibitor, we observed that the level of IL‐4 in IBD model mice exhibiting depression significantly decreased, whereas neuroinflammation did not show improvement. Here, IL4 is linked to inflammatory bowel disease.